MAPT and early-onset autosomal dominant Alzheimer disease: This study also found significant associations between CSF 14-3-3β levels and CSF biomarkers of p-tau, t-tau, pTau/Aβ42 ratios and GAP-43, as well as other Alzheimer’s disease biomarkers such as Aβ-PET.